mrk Stock Quote - stock news and information

MERCK & CO., Inc.

(NYSE: MRK)Add to My Watchlist

Detailed Quote

News

Last Price	36.47 ( 4:15 PM EST)
Change (%)	-0.12 (-0.33%)
Volume	17,142,688
Open	36.93
Previous Close	36.59
Day High	37.17
Day Low	36.32
Bid	36.38 x 200
Ask	36.47 x 400

Intraday

3 Month

6 Month

1 Year

Average Volume	15,767,400
Shares Outstanding	3.10B
Market Cap	113.0B
Year High	41.56
Year Low	20.05
Earnings Per Share	1.91
P/E Ratio	19.1
Dividend	N/A
Yield	N/A

Symbol	Last	Change (%)
0IJ9	40068.63	+0.00 (+0.00)
TEVA	213.50	+1.40 (+0.66%)
NVOB	372.00	+0.00 (+0.00)
NVOB	336.00	+0.00 (+0.00)
JNJ	62.76	+0.39 (+0.63%)
PFZ	18.45	+0.00 (+0.00)
PFZ	17.90	-0.09 (-0.50%)
PFE	17.88	+0.04 (+0.22%)

Mon, Feb 01, 2010
	Merck CEO Clark Gets a Helipad on Top of Old Schering HQ The Kenilworth, N.J., planning board has approved a helicopter pad to be built for Merck MRK on top of a seven-story garage at the former Schering-Plough HQ. A look at Merck's most recent proxy form (see page 42) suggests that mostly it's for CEO Richard Clark's use. by Jim Edwards - BNET.com
Thu, Jan 28, 2010
	Markets Fall on Data, But P&G Results Limit Losses By Ryan VlastelicaNEW YORK (Reuters) - U.S. stocks fell on Thursday after weaker-than-expected data on durable goods and jobless claims fueled uncertainty about the economy's recovery, and outlooks from Motorola and Qualcomm hit tech shares.Initial jobless claims fell in the latest week, though not as much as expected, while durable... - Reuters articles \| B...
Tue, Jan 19, 2010
	Wall St Gains on Mass. Vote Bets, Tech; IBM Off Late By Ellis MnyanduNEW YORK (Reuters) - Stocks rose broadly on Tuesday, lifting the Dow and the S&P 500 to fresh 15-month closing highs as investors bet a potential Republican victory in Massachusetts' Senate race could stall Obama's reform agenda.Wall Street also got a boost from technology shares, which rallied in... - Reuters articles \| B...
	Bets on Mass. Vote, Tech Lift Wall Street By Ellis MnyanduNEW YORK (Reuters) - Stocks rose broadly on Tuesday, lifting the Dow and the S&P 500 to fresh 15-month closing highs as investors bet a potential Republican victory in Massachusetts' Senate race could stall Obama's reform agenda.Wall Street also got a boost from technology shares, which rallied in... - Reuters articles \| B...
	Wall Street Rallies on Close Massachusetts Race By Ellis MnyanduNEW YORK (Reuters) - Stocks rose broadly on Tuesday as investors scooped up healthcare shares on bets that a potential Republican victory in Massachusetts' Senate race could stall U.S. President Barack Obama's reforms and remove a threat to profits in the sector.The S&P Healthcare Index climbed nearly... - Reuters articles \| B...
More Featured Content

Today
	AstraZeneca Goes to the Well One Last Time Blockbuster statins may be due for death-by-patent cliff in the next few years but Big Pharma hasn’t finished squeezing all the profits it can out of the cholesterol-lowering money-making machines. AstraZeneca (AZN) announced Tuesday that the FDA has approved its blockbuster statin Crestor for a whole new patient population that doesn’t have high cholesterol. The drug will now also be prescribed to men over the age of 50 and women over 60 years old who have an increased risk of heart disease. Leerink Swann analyst Seamus Fernandez estimates that this will increase the number of Crestor prescriptions by another ... - Minyanville
	Biogen: Heart Drug Data Doesn't Support Continued Development Biogen: Heart Drug Data Doesn't Support Continued Development - FOXBusiness.com
	Merck’s Price Target, Estimates Raised at Barclays Capital (MRK) Drugmaker Merck & Co., Inc. (MRK) saw its price target and earnings estimates raised on Tuesday by analysts at Barclays Capital, ahead of its fourth quarter earnings report. The analyst boosted its price target for MRK, which had closed at $36.59 on Monday, to $43 from $40. Barclays also raised its 2009 and 2010 earnings estimates [...] - Dividend Stocks - Th...
	Merck (MRK) Gets 4 Star Buy Rating From S&P With 3.9% Dividend Yield Merck (NYSE: MRK) ended the last trading session at $36.73. So far the stock has hit a 52-week low of $20.05 and 52-week high of $41.56. Merck stock has been showing support around 35.28 and resistance in the 37.80 range. Technical indicators for the stock are Bearish and S&P gives MRK a positive 4 ...(Click the story link or go to http://www.marketintelligencecenter.com for the full story) - MarketIntelligenceCe...
	What Bipartisan Health-Care Reform Means for Investors Republicans and Democrats will debate on TV, but little may come of it. - Fool.com Headlines
More News

Today
	Critical Alerts for Merck, Lowe's, MEMC Electronic Materials, Lennar, and Kinross Gold Released by Seven Summits Research - PR Newswire
Wed, Feb 03, 2010
	Merc Announces Election of New Director - CCN
	Merc Announces Election of New Director - Marketwire
Thu, Jan 28, 2010
	MWB Consulting Joins SAFE-BioPharma Association - Business Wire
Tue, Jan 26, 2010
	U.S. District Court Rules Against Merck in TEMODAR® (temozolomide) Patent Lawsuit - Business Wire
More Press Releases

Mon, Feb 08, 2010
	(MRK) Merck & Company Earns EU Approval For Elonva Recently, Merck & Co. Inc. (MRK) received approval from the European Commission (EC) for its fertility drug Elonva (corifollitropin alfa injection). The drug will be used as a treatment in controlled ovarian stimulation (COS) coupled with a GnRH antagonist for the development of multiple follicles in women who have participated in an assisted reproductive technology [...] (MRK) Merck & Company Earns EU Approval For Elonva - Stock Blog Hub
	Approaching Support- Merck New York, Feb 8th (TradersHuddle.com) - Shares of Merck & Co. Inc. (NYSE:MRK) are trading very close to calculated support at $35.82 with current price action closing at just $36.59 places the stock price near levels where traders will start paying attention. Merck & Co., Inc. (NYSE:MRK), the global pharmaceutical company that develops, . Read More -- - TradersHuddle.com
	EU Approves Merck’s Elonva « Zacks Investment Research » Recently, Merck & Co. Inc. (MRK) received approval from the European Commission (EC) for its fertility drug Elonva (corifollitropin alfa injection). The drug will be used as a treatment in controlled ovarian stimulation (COS) coupled with a GnRH antagonist for the development of multiple follicles in women who have participated in an assisted reproductive technology ... - Daily Markets
Thu, Feb 04, 2010
	Stocks Plunged on Sovereign Debt Woes and Jobless Claims. Dow Laggards: BAC, JPM, AA, MRK, and GE. CSCO Lone Gain in the Dow New York, Feb 4th (TradersHuddle.com) - Stocks took a beating on concern that out of control sovereign debt, particularly in the euro zone, and an unexpected increase in jobless claims will derail the global economic recovery. The Dollar surged against the euro as investors sold risky assets and sought safe haven ass. Read More -- - TradersHuddle.com
	Wall Street Plummets On Jobs Data, Bank of America (NYSE: BAC) Sinks US stocks tumbled on Thursday as financials and commodity shares slumped on worse-than expected jobless claims data. Worries over Europe's sovereign debts also added to the gloom.[More...] - home: iStockAnalyst....
More Blogs

Tue, Jan 26, 2010
	January 26, 2010 - Today's Industrial Market News from Industrialinfo.com Companies featured in this segment: Pfizer Incorporated (NYSE:PFE), Roche Holding Limited (OTC:RHHBY), Merck & Company Incorporated (NYSE:MRK), EDF Energies Nouvelles SA (EPA:EEN), GDF Suez SA (EPA:GSZ), Poweo SA (EPA:ALPWO), Rio Tinto plc (NYSE:RTP), Kumba Iron Ore Limited (JNB:KIO) - Industrial Info Dail...
Wed, Nov 11, 2009
	Dorsey Wright's Podcast 208 - Expand Your Horizons Tom Dorsey and Tammy DeRosier - Expand Your Horizons - Dorsey Wright
Mon, Oct 19, 2009
	October 19, 2009 - Today's Industrial Market News from Industrialinfo.com Companies featured in this segment: FPL Group Incorporated (NYSE:FPL), Siemens AG (NYSE:SI), GlaxoSmithKline plc (NYSE:GSK), AstraZeneca plc (NYSE:AZN), Schering-Plough Corporation (NYSE:SGP), Merck & Company, Incorporated (NYSE:MRK), Novartis AG (NYSE:NVS), Xstrata plc (LON:XTA) - Industrial Info Dail...
Mon, Aug 17, 2009
	August 17, 2009 - Today's Industrial Market News from Industrialinfo.com Companies featured in this segment: FirstEnergy Corporation (NYSE:FE), Exxon Mobil Corporation (NYSE:XOM), BP plc (NYSE:BP), Siemen AG (NYSE:SI), Chevron Corporation (Chevron) (NYSE:CVX), Royal Dutch Shell plc (NYSE:RDS.A), InterOil Corporation USA (NYSE:IOC), GlaxoSmithKline plc (NYSE:GSK), Pfizer Incorporated (NYSE:PFE), Novartis AG (NYSE:NVS), Eli Lilly & Company (NYSE:LLY), AstraZeneca plc (NYSE:AZN), Wyeth (NYSE:WYE), Genzyme Corporation (NASDAQ:GENZ), Merck & Company, Incorporated (NYSE:MRK), Johnson & Johnson (NYSE:JNJ), Santos Limited (OTC:STOSY), Petronet LNG Limited (BSE:532522) - Industrial Info Dail...
Wed, Aug 12, 2009
	August 12, 2009 - Today's Industrial Market News from Industrialinfo.com Companies featured in this segment: Pfizer Incorporated (NYSE:PFE), GlaxoSmithKline plc (NYSE:GSK), Merck & Company Incorporated (NYSE:MRK), IMS Health Incorporated (NYSE:RX), Drax Group plc (LSE:DRX), KBR Incorporated (NYSE:KBR), ConocoPhillips (NYSE:COP), OAO Gazprom (OTC:OGZPY), Vestas Wind Systems A/S (CPH:VWS) - Industrial Info Dail...
More Podcasts

Tue, Feb 16, 10		Q4 2009 Earnings Archive for MRK
Tue, Jan 12, 10		Special Conference Merck and Co., Inc. at JPMorgan Healthcare Conference Archive for MRK
Wed, Jan 06, 10		Special Conference Merck and Co., Inc. at Goldman Sachs CEO Unplugged Conference Archive for MRK
Thu, Nov 12, 09		Special Conference Merck and Co., Inc. at Credit Suisse Healthcare Conference Archive for MRK
Thu, Oct 22, 09		Q3 2009 Earnings Archive for MRK

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Market News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs

MoneyWatch.com

About CBS MoneyWatch.com

MoneyWatch.com is the premier destination for smart, practical personal finance advice about your retirement, investing, savings, career and real estate. A joint effort between the news powerhouse CBS and the business experts at BNET, MoneyWatch.com is the place to go for personal financial insight you can trust.

Meet the CBS MoneyWatch.com Team

Feeds

Site Help & Feedback

Beta - Give us your feedback

About CBS MoneyWatch.com

Feeds

Site Help & Feedback

Your Work Four Secrets to Liking Your Work

Four Secrets to Liking Your Work

Your Industry Insights into your industry

Smart Business for Tough Times

Your Money Be Smarter, Look Younger, Perform Better, and Keep Your Job

Be Smarter, Look Younger, Perform Better, and Keep Your Job